SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Long-term Debt

Borrowings due after more than one year.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Long-term Debt · Q1 FY2026 · quarter ended Mar 2026

Long-term debt of $0 in Q1 FY2026

Q1 FY2026 long-term debt was $0.

Context

  • Long-term debt amounted to 0.0% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Long-term Debt history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Long-term Debt vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so long-term debt is compared through growth and share of total assets rather than absolute size.
  • Long-term debt amounts to 0.0% of total assets for SGP, versus a peer median of 9.8%.
SGP Competitors
Long-term Debt for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$5.07B USD+2.9%+28.9%36.6%
ALCAlcon Inc.Sep 2026$4.69B USD+12.8%-2.9%14.9%
GKOSGlaukos CorporationJun 2026$102.84M USD—-49.7%11.2%
OCULOcular Therapeutix, Inc.Mar 2026$72.06M USD+4.1%+11.1%9.8%
SGHTSight Sciences, Inc.Mar 2026$36.74M USD-7.2%+6.6%33.5%
RXSTRxSight, Inc.Mar 2026$9.32M USD—-37.3%3.1%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$0 USD——0.0%
STAASTAAR Surgical CompanyApr 2026$0 USD——0.0%
OCSOculis Holding AGMar 2026CHF 0 CHF——0.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding SGP) —+3.5%+1.8%9.8%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.